Fusion Pharmaceuticals Inc.
Fusion Pharmaceuticals Inc. (FUSN) Stock Overview
Explore Fusion Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.8B
P/E Ratio
-29.19
EPS (TTM)
$-1.40
ROE
-0.27%
FUSN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Fusion Pharmaceuticals Inc. (FUSN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $36.67.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -29.19 and a market capitalization of 1.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.